Induction of cell cycle arrest and apoptosis in human prostate carcinoma cells by a recombinant adenovirus expressing p27Kip1

Prostate

Volumn 53, Issue 1, 2002, Pages 77-87

  Katner, Adrienne L ^a   Hoang, Quoc Bao Ly ^a   Gootam, Praveen ^a   Jaruga, Ewa ^a   Ma, Quangwei ^a   Gnarra, James ^a   Rayford, Walter ^a,b  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Cyclin dependent kinase inhibitors; Prostate cancer DU 145 LNCaP, PC 3

Indexed keywords

ADENOVIRUS VECTOR; BROXURIDINE; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE INHIBITOR; FLUORESCEIN ISOTHIOCYANATE; LIPOCORTIN 5; PROTEIN KINASE; PROTEIN P27; VIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL COUNT; CELL CYCLE; CELL CYCLE S PHASE; CELL PROLIFERATION; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVITY; GENE THERAPY; GROWTH CURVE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN EXPRESSION; TUMOR GROWTH; VIRUS RECOMBINANT; WESTERN BLOTTING;

ADENOVIRUSES, HUMAN; APOPTOSIS; CARCINOMA; CELL CYCLE; CELL CYCLE PROTEINS; CYCLIN-DEPENDENT KINASE INHIBITOR P27; ENZYME INHIBITORS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC VECTORS; HUMANS; MALE; PROSTATIC NEOPLASMS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 0037106038     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/pros.10124     Document Type: Article

References (32)

1. Cancer statistics
2. Coordinated changes in cell cycle machinery occur during keratinocyte terminal differentiation
3. Role of cyclin-dependent kinases and their inhibitors in cellular differentiation and development
4. A recombinant adenovirus expressing p27 Kip1 induces cell cycle arrest and loss of Cyclin-Cdk activity in human breast cancer cells
5. Over-expression of p27 inhibits the growth of both normal and transformed human mammary epithelial cells
6. Adenoviral expression of the cyclin-dependent kinase inhibitor p27 Kip1: A strategy for breast cancer gene therapy
7. Expression of cell cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients
8. Prognostic role of the cyclin-dependent kinase inhibitor p27 in non-small cell lung cancer
9. Association of p27 Kip1 levels with recurrence and survival in patients with stage C prostate carcinoma
10. (Kip1) and costimulate proliferation of MDA PCa2a and MDA Pca2b prostate cancer cells
11. Low p27 expression predicts poor disease-free survival in patients with prostate cancer
12. Loss of cyclin-dependent kinase inhibitor p27Kip1 is a novel prognostic factor in localized human prostate adenocarcinoma
13. Distinct altered patterns of p27Kip1 gene expression in benign prostatic hyperplasia and prostatic carcinoma
14. Expression of p27Kip1 in prostatic adenocarcinoma
15. (Kip1) induces cell cycle arrest and apoptosis in human renal carcinoma cells
16. p27Kip1 over-expression causes apoptotic death of mammalian cells
17. Modulation of apoptosis by the cyclin-dependent kinase inhibitor p27Kip1
18. Comparison of the effectiveness of adenovirus vectors expressing cyclin kinase inhibitors p16INK4A, p18INK4C, p21WAFKIP1 and p27KIP1 in inducing cell cycle arrest, apoptosis and inhibition of tumorigenicity
19. Promoting apoptosis: A novel activity associated with cyclin-dependent kinase inhibitor p27
20. Over-expression of p27Kip1 induces growth arrest and apoptosis mediated by changes of pRb expression in lung cancer cell lines
21. Comparison of the effects of recombinant adenovirus-mediated expression of wild-type p53 and p27Kip1 on cell cycle arrest and apoptosis in SUDHL-1 cells derived from anaplastic large cell lymphoma
22. The dual impact of coxsackie and adenovirus receptor expression on human prostate cancer gene therapy
23. Ablation of the CDK inhibitor p57 Kip2 results in increased apoptosis and delayed differentiation during mouse development
24. Cytotoxic effects of Adenovirus-mediated wild type p53 protein expression in normal and tumor mammary epithelial cells
25. p21-containing cyclin kinases exist in both active and inactive states
26. New functional activities for the p21 family of CDK inhibitors
27. The p27(Cip1) and p27(Kip1) CDK inhibitors are essential activators of cyclin D-dependent kinases in murine fibroblasts
28. Premature p34Cdc2 activation required for apoptosis
29. Growth arrest by the cyclin-dependent kinase inhibitor p27Kip1 is abrogated by c-Myc
30. Viruses as anti-tumor weapons: Defining conditions for tumor remission
31. Chimeric PSA enhancers exhibit augmented activity in prostate cancer gene therapy vectors
32. Life, death, and the pursuit of apoptosis